.@bmsnews @JNJNews prematurely halt ph3 LIBREXIA-ACS assessing milvexian (FXIa inhibitor) in pts presenting with ACS to reduce MACE risk v placebo. https://t.co/PqRhC2HUk3 @statnews @ADeAngelis_bio @matthewherper Some of my thoughts on this interesting target 👇 Similar story

The ⁦@CiccaroneCenter⁩ salutes the new El Jefe of Vandy 🫀- proud ⁦@hopkinsheart⁩ & Ciccarone Ctr alumnus as well as a champion wrestler 🤼 Dr. Andrew DeFilippis!

VESALIUS & the Anatomy of High-Risk Prevention | New England Journal of Medicine - editorial led by ⁦@ChiadiNdumele⁩ ⁦@CiccaroneCenter⁩ ⁦@HopkinsMedicine⁩ ⁦@hopkinsheart⁩

Dr. Michael Blaha making the case that GLP1 RA should be used in high risk patients. Benefit may be higher in those with elevated CAC.

🩺 An Ounce of Prevention: Oct 25, 2025 | 9–10 AM ET Dr. Anum Minhas: CV risk & lipids in young women with preeclampsia & SCAD Dr. Seamus Whelton: Personalizing CVD treatment goals Register today ⬇️ #CVprev @DrAnumMinhas @seamuswhelton

The @inacc is in DC advocating for ❤️healthy issues! @ACCinTouch @Cardiology @drparinpatel @Vijayrao7474 @MinnowWalsh @JClaryMD @Andrea_Price317 @AngelaRaymer22 @DickKovacs @OliviaBlazek #ACCLegConf #ACCLegConf25

📢NEWS: Amgen announces topline results from its Phase 3 trial evaluating cardiovascular outcomes in high-risk patients without prior heart attack or stroke. Full data readout at @American_Heart Scientific Sessions #AHA25. 🔗 Learn more: https://t.co/yq59tLVXgr $AMGN

Congratulations to Dr. Ray Dusman, the recipient of the 2025 @inacc Career Achievement Award! @ParkviewHealth @ACCinTouch @drparinpatel @kunaljhamd @MinnowWalsh @Vijayrao7474

Lee Goldberg presenting the keynote lecture at ⁦@inacc⁩ statewide conference. Passionate heart failure cardiologist presenting high level overview of ⁦@ACCinTouch⁩ strategic initiatives for our CV profession ⁦@MinnowWalsh⁩ ⁦@drparinpatel⁩

At the 2025 ACC-IN Annual Meeting, it is inspiring to see Dr. Raymond Dusman honored with the Career Achievement Award. A well-deserved recognition of his impact in the field. @inacc @Vijayrao7474 @drparinpatel @EdwardFryMD @DrRyanPDaly @DickKovacs @MinnowWalsh

⁦@drparinpatel⁩ kicking of the ⁦@inacc⁩ annual statewide meeting in Indy! Looking forward to great science, catching up with and making new friends! ⁦@DrRyanPDaly⁩

Don't miss out on the @inacc Annual Meeting on 9/13/25 in Indianapolis! Hope to see you there! https://t.co/OBl4NTr9Ot @drparinpatel @Vijayrao7474 @ikutkutMD @Aheartdoc @KeyurVoraMD @kunaljhamd @HunterMwansa @OliviaBlazek @MinnowWalsh @DickKovacs

A new clinical obesity definition — focused on body fat, not just BMI — is now being implemented in preventive cardiology clinics. Practical steps towards individualized, precision care. Read more: https://t.co/wesrifacwz #ObesityMedicine #PreventiveCardiology #PrecisionHealth

In @JACCJournals, Kriyana Reddy, Ashwin Nathan & @jaygirimd (@PennCardiology) discuss the economics of transcatheter interventions @PennCVI @PennLDI @VAPhiladelphia https://t.co/cYOY7cXf6H

An honor to work with @WendyPost9 and @rblument1 reviewing the current data for colchicine to treat CVD. https://t.co/rFuaW2E7XW

https://t.co/53tAkHHTZZ

I'll be attending the amazing Indiana-ACC Annual Meeting 2025. Let me know if you're planning to attend so that we can say Hi! 👋 Or register now and join us at the event! https://t.co/1c1XNbq5qu @Vijayrao7474 @drparinpatel @inacc

Want to know more about TEE vs. CT in the Evaluation of the Left Atrium? Check out the @inacc Best Practices discussion with @DrRyanPDaly @BrunoLimaMDPhD @drparinpatel https://t.co/QgDOSY0CTC @Vijayrao7474 @MinnowWalsh @ACCinTouch @AnkurKalraMD

Reimagining obesity research: New insights call for novel methods to study how obesity leads to multimorbidity and disease progression clusters. Rethinking our analytical tools could shift prevention strategies. https://t.co/HFfjw3T43V #ObesityResearch #CVDPrevention

Do not miss this new publication by our own @yao_zhiqi !